injectable glp 1 GLP-1 drugs don't work for everyone. But personalized obesity care in the future might How GLP-1 Injections Are Used:

Although NE release and subsequent formation of NETs are key components of the innate inflammatory response to pathogens (60, 110, 111), the excessive release of NE that occurs in bronchiectasis contributes to disease progression

7 Similarly, a joint guideline by the American Diabetes Association (ADA) and European Association for the Study of Diabetes (EASD) recommends GLP-1RAs as second- or third-line therapy in patients with predominantly atherosclerotic cardiovascular disease, a compelling need to minimise hypoglycaemia or a need to promote weight loss

Our team strongly recommends using bacteriostatic water for reconstitution

A 52-week phase 2 trial on AMG133 in people with overweight and obesity is ongoing (NCT05669599)

In the study by Mehta et al (Mehta A), children with congenital isolated GH deficiency demonstrated growth retardation as already at 6 months of age (26 10 SD and 22 13 SD in weight and length, respectively) prior to starting treatment